← SearchNOVEL CXCR3/CXCR7-DIRECTED BIOLOGICAL ANTAGONIST FOR INHIBITION OF BREAST CANCER PROGRESSION$530,559FY2011Department of the ArmyDODThe Morehouse School Of Medicine, Inc.InvestigatorsView source on USAspending →